Nuveen
LUNG icon

Nuveen’s Pulmonx LUNG Stock Holding History

Nuveen’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-69,108
Closed -$89.2K – 3808
2026
Q1 		$89.2K Buy
69,108
+318
+0.5% +$525 ﹤0.01% 3182
2025
Q4 		$152K Hold
68,790
– – ﹤0.01% 3186
2025
Q3 		$111K Hold
68,790
– – ﹤0.01% 3217
2025
Q2 		$178K Sell
68,790
-129,733
-65% -$512K ﹤0.01% 3179
2025
Q1 		$1.34M Buy
198,523
+19,305
+11% +$137K ﹤0.01% 2508
2024
Q4 		$1.22M Hold
179,218
– – ﹤0.01% 2626
2024
Q3 		$1.49M Buy
179,218
+96,570
+117% +$699K ﹤0.01% 2572
2024
Q2 		$524K Sell
82,648
-72,016
-47% -$554K ﹤0.01% 2974
2024
Q1 		$1.43M Sell
154,664
-55,809
-27% -$654K ﹤0.01% 2550
2023
Q4 		$2.68M Sell
210,473
-42,970
-17% -$448K ﹤0.01% 2279
2023
Q3 		$2.62M Sell
253,443
-506
-0.2% -$5.86K ﹤0.01% 2184
2023
Q2 		$3.33M Buy
253,949
+17,619
+7% +$216K ﹤0.01% 2110
2023
Q1 		$2.64M Buy
236,330
+71,670
+44% +$708K ﹤0.01% 2224
2022
Q4 		$1.39M Buy
164,660
+77,184
+88% +$734K ﹤0.01% 2540
2022
Q3 		$1.46M Buy
87,476
+240
+0.3% +$4.42K ﹤0.01% 2563
2022
Q2 		$1.28M Sell
87,236
-13,019
-13% -$268K ﹤0.01% 2678
2022
Q1 		$2.38M Sell
100,255
-14,980
-13% -$387K ﹤0.01% 2423
2021
Q4 		$3.69M Buy
115,235
+10,453
+10% +$382K ﹤0.01% 2275
2021
Q3 		$3.77M Sell
104,782
-804
-0.8% -$31.6K ﹤0.01% 2362
2021
Q2 		$4.66M Buy
105,586
+43,661
+71% +$1.9M ﹤0.01% 2291
2021
Q1 		$2.83M Buy
61,925
+3,582
+6% +$205K ﹤0.01% 2448
2020
Q4 		$4.03M Buy
+58,343
New +$2.86M ﹤0.01% 2180

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Nuveen's LUNG Position: Q2 2026 in Review

Nuveen sold out of Pulmonx (LUNG) in Q2 2026, closing a stake of 69,108 shares — an estimated $89.2K sold.

Nuveen first reported a position in LUNG in Q4 2020 and held it in 22 quarters. The position peaked at $4.66M in Q2 2021. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Nuveen reported no remaining Pulmonx position as of Q2 2026 after selling out during the quarter.
  • Nuveen sold 69,108 Pulmonx shares in Q2 2026, an estimated $89.2K.
  • Nuveen first reported a position in Pulmonx in Q4 2020 and held it in 22 quarters.
  • Nuveen's Pulmonx position peaked at $4.66M in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.